Background/aim: To study the prevalence and trend of acquired drug resistance to the first line antitubercular drugs.
Materials And Methods: Sputum of 215 previously treated adult pulmonary tuberculosis (TB) patients over a period of 2002-2006 were subjected to culture and sensitivity testing against common antitubercular drugs.
Result: Growth of Mycobacterium tuberculosis was obtained from sputum specimen of 184 (85.58%) of the 215 patients who were studied; Overall, 113 (62.77%) of these were resistant to at least one antitubercular drug. Resistance to isoniazid was most common (62.22%) followed by rifampicin (57.22%). Multidrug resistance (MDR) was observed in 103 (57.22%) cases. During the five-year study period, an increasing trend in drug resistance including MDR-TB was observed.
Conclusion: This study showed increasing trend in drug resistance including MDR-TB in five years.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876693 | PMC |
http://dx.doi.org/10.4103/0970-2113.56342 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!